P2.05-006 Credentialing of Radiotherapy Centres in Australasia for a Phase III Clinical Trial on SABR (TROG 09.02 CHISEL)

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.11.033 ◽

2017 ◽

Vol 12 (11) ◽

pp. S2405-S2406

Author(s):

T. Kron ◽

B. Chesson ◽

N. Hardcastle ◽

M. Burns ◽

M. Crain ◽

...

Keyword(s):

Clinical Trial ◽

Phase Iii ◽

Phase Iii Clinical Trial

Get full-text (via PubEx)

NIH Announces Phase III Clinical Trial of Creatine for Parkinson's Disease

PsycEXTRA Dataset ◽

10.1037/e607462007-001 ◽

2007 ◽

Keyword(s):

Parkinson’S Disease ◽

Clinical Trial ◽

Parkinson's Disease ◽

Phase Iii ◽

Phase Iii Clinical Trial

Get full-text (via PubEx)

Phase III Clinical Trial Comparing Iopamidol 250 mgI/mL and Iopamidol 300mgI/mL in Cerebral Angiography: Multicenteric, Randomized and Double Blind Study

Journal of the Korean Radiological Society ◽

10.3348/jkrs.2007.57.6.501 ◽

2007 ◽

Vol 57 (6) ◽

pp. 501

Author(s):

Hyobin Seo ◽

Moon Hee Han ◽

Bae Ju Kwon ◽

So Hyang Im ◽

Cheolkyu Jung ◽

...

Keyword(s):

Clinical Trial ◽

Cerebral Angiography ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Phase Iii Clinical Trial

Get full-text (via PubEx)

Faculty Opinions recommendation of Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725828169.793561106 ◽

2019 ◽

Author(s):

Mark Bower

Keyword(s):

Clinical Trial ◽

Kaposi's Sarcoma ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Kaposi’S Sarcoma ◽

Phase Iii ◽

Phase Iii Clinical Trial

Get full-text (via PubEx)

Faculty Opinions recommendation of A randomized phase III clinical trial of plecanatide, a uroguanylin analog, in patients with chronic idiopathic constipation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727289372.793551519 ◽

2018 ◽

Author(s):

Adil Bharucha

Keyword(s):

Clinical Trial ◽

Phase Iii ◽

Idiopathic Constipation ◽

Phase Iii Clinical Trial ◽

Chronic Idiopathic Constipation

Get full-text (via PubEx)

Faculty Opinions recommendation of A randomized phase III clinical trial of plecanatide, a uroguanylin analog, in patients with chronic idiopathic constipation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727289372.793528809 ◽

2017 ◽

Author(s):

Aldo Infantino

Keyword(s):

Clinical Trial ◽

Phase Iii ◽

Idiopathic Constipation ◽

Phase Iii Clinical Trial ◽

Chronic Idiopathic Constipation

Get full-text (via PubEx)

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

Annals of Oncology ◽

10.1093/annonc/mdz402 ◽

2019 ◽

Vol 30 (12) ◽

pp. 1950-1958 ◽

Cited By ~ 20

Author(s):

C. Morizane ◽

T. Okusaka ◽

J. Mizusawa ◽

H. Katayama ◽

M. Ueno ◽

...

Keyword(s):

Clinical Trial ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Iii ◽

Phase Iii Clinical Trial ◽

Tract Cancer

Get full-text (via PubEx)

Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial

Journal of Alzheimer s Disease ◽

10.3233/jad-170560 ◽

2017 ◽

Vol 61 (1) ◽

pp. 435-457 ◽

Cited By ~ 52

Author(s):

Gordon K. Wilcock ◽

Serge Gauthier ◽

Giovanni B. Frisoni ◽

Jianping Jia ◽

Jiri H. Hardlund ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Clinical Trial ◽

Primary Outcome ◽

Low Dose ◽

Cohort Analysis ◽

Phase Iii ◽

Phase Iii Clinical Trial

Get full-text (via PubEx)

Industry Watch

Asia-Pacific Biotech News ◽

10.1142/s0219030307001607 ◽

2007 ◽

Vol 11 (22) ◽

pp. 1468-1482

Keyword(s):

Clinical Trial ◽

Stem Cell ◽

Tamil Nadu ◽

Point Of Care ◽

Opioid Therapy ◽

Phase Iii ◽

Cancer Drugs ◽

Phase Iii Clinical Trial ◽

Chinese Academy Of Sciences ◽

Academy Of Sciences

Arana Therapeutics Completes Project with CSL. Biotech Capital to Invest $2.2 Million in Generic Health Pty Ltd. Phase III Clinical Trial for “Dual Opioid” Therapy. Beijing Med-Pharm Announces Exclusive Agreement to Market Enablex in China. Genesis Pharmaceuticals Collaborates with the Institute of Microbiology, Chinese Academy of Sciences. NPIL and Merck Collaborate on Cancer Drugs. LifeCell Launches First Stem Cell Center in Tamil Nadu. Japan's Bioventures Today — BCS, Inc. Bio-Rad Launches In2it A1C Analyzer for Point-Of-Care Diabetes Testing.

Get full-text (via PubEx)

Covariate-Adjusted Adaptive Designs for Continuous Responses in a Phase III Clinical Trial: Recommendation for Practice

Journal of Biopharmaceutical Statistics ◽

10.1080/10543400500508929 ◽

2006 ◽

Vol 16 (2) ◽

pp. 227-239 ◽

Cited By ~ 5

Author(s):

Atanu Biswas ◽

Hui-Hsin Huang ◽

Wen-Tao Huang

Keyword(s):

Clinical Trial ◽

Adaptive Designs ◽

Phase Iii ◽

Phase Iii Clinical Trial ◽

Continuous Responses

Get full-text (via PubEx)

Bendamustine versus chlorambucil in treatment of chronic lymphocytic leukaemia in China: a randomized, open-label, parallel-controlled, phase III clinical trial

Investigational New Drugs ◽

10.1007/s10637-021-01206-2 ◽

2022 ◽

Author(s):

Daobin Zhou ◽

Wei Xu ◽

Hongbing Ma ◽

Chunting Zhao ◽

Yu Hu ◽

...

Keyword(s):

Clinical Trial ◽

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Phase Iii ◽

Open Label ◽

Phase Iii Clinical Trial

Get full-text (via PubEx)